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Clostridium Difﬁcile Infection in the United
States: A National Study Assessing
Preventive Practices Used and Perceptions
of Practice Evidence
Sanjay Saint, MD, MPH;1,2,3 Karen E. Fowler, MPH;1,3
Sarah L. Krein, PhD, RN;1,2,3 David Ratz, MS;1,3
Scott A. Flanders, MD;2,3 Erik R. Dubberke, MD, MSPH;4
M. Todd Greene, PhD, MPH2,3

We surveyed 571 US hospitals about practices used to prevent
Clostridium difﬁcile infection (CDI). Most hospitals reported regularly
using key CDI prevention practices, and perceived their strength of
evidence as high. The largest discrepancy between regular use and
perceived evidence strength occurred with antimicrobial stewardship
programs.
Infect. Control Hosp. Epidemiol. 2 01 5; 3 6( 8) :9 6 9– 9 71

The incidence of Clostridium difﬁcile infection (CDI), a common,
costly, and potentially life-threatening healthcare-associated
infection, has increased dramatically.1 Several practices are
recommended to prevent CDI in acute care hospitals.2,3 Little is
known about the extent to which US hospitals are implementing
these recommended practices to prevent CDI. It is also useful to
understand how those who might champion infection prevention
activities view current CDI prevention recommendations. We
therefore conducted a national study to address these issues.

m e th o d s

Survey Measures
The survey instrument, which has been previously described,4–6
included questions about facility characteristics, the infection
control program, infection preventionists, and frequency of use
and perception of evidence to determine hospital practices related to prevention and monitoring of device-associated infections. The present survey included questions related to CDI
prevention. Respondents were asked how frequently certain CDI
practices were used for adults in their acute care facility. Frequency was measured on a scale from 1 (never) to 5 (always),
with “regular use” deﬁned by a rating of 4 or 5. The CDI prevention practices of interest, derived primarily from the 2008
Society for Healthcare Epidemiology of America (SHEA) Compendium and other studies,3 were the following: (1) contact
precautions (gloves and gowns) while caring for infected
patients; (2) private rooms or cohorting of infected patients;
(3) soap and water hand hygiene before entering and exiting the
room of infected patients; (4) terminal cleaning and disinfecting
of an infected patient’s room with a cleansing product containing chlorine bleach; (5) routine daily cleaning of high-touch
surfaces of infected patients; (6) disposable (not reusable) thermometers for infected patients; and (7) participating in an
antimicrobial stewardship program. Respondents were also
asked about their perceptions of the strength of evidence for each
of the above practices, using a Likert scale from 1 (no evidence)
to 5 (extremely strong evidence). For our descriptive analysis of
perceived strength of evidence, ratings of 4 or 5 represent
“strong” evidence.
Sampling weights based on the inverse probability of selection and response in each bed size stratum were utilized to
create nationally representative estimates for CDI practices
and hospital characteristics. Descriptive statistics are reported
as weighted proportions for categorical variables and weighted
means for continuous variables.

Data Collection
The current study was part of an ongoing panel survey that
began in 2005 in which we asked hospitals across the United
States what practices they are using to prevent common
healthcare-associated infections.4 The most recent survey was
sent in May 2013 to infection control coordinators at 571
hospitals across the nation. The survey sample included a
stratiﬁed random sample of non-federal general medical and
surgical hospitals with 50 or more beds and with intensive care
beds. Description of the sample selection using the AHA
Annual Survey Database and sample stratiﬁcation is described
elsewhere.4 Surveys were mailed to all hospitals along with a
cover letter, a pre-paid return envelope, and a $10 incentive.
Survey reminders were sent after the initial mailing.
Institutional review board approval was obtained from the
University of Michigan and the Veterans Affairs (VA) Ann
Arbor Healthcare System.

resul ts
The overall survey response rate was 71% (403 of 571); an
additional 5 respondents did not answer the CDI questions,
leaving a ﬁnal sample of 398. Table 1 provides an overview of
the responding hospitals along with their responses to several
CDI-related questions. While 97% of hospitals reported
having an established facilitywide surveillance system for
monitoring CDI rates, only 24% have a written policy to
routinely test for C. difﬁcile when patients have diarrhea while
on antibiotics or within several months of taking them. A total
of 76% of hospitals reported that preventing CDI was very or
extremely important to the leadership of their hospital.
Figure 1 shows the frequency of regular use and perceived
strength of evidence for each of the key CDI preventive practices examined. Greater than 90% reported that their hospitals
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table 1.
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Hospital Characteristics and C. difﬁcile Prevention Practices (N = 398)
% (95% CI)a

Characteristic
No. of hospital beds, mean (95% CI)
No. of intensive care unit beds, mean (95% CI)
Facility afﬁliated with a medical school
Facility has hospitalists
Facility has a hospital epidemiologist
No. of full-time equivalent infection preventionists at facility, mean (95% CI)
Facility has a written policy to routinely test for C. difﬁcile when patients have diarrhea while on antibiotics or
within several months of taking them
Established facility-wide surveillance system for monitoring C. difﬁcile infection rates
Facility reports C. difﬁcile infection rates to direct care providers
Perception of how important it is to hospital leadership at your facility to prevent C. difﬁcile infection,
very/extremely important

233 (222–245)
22 (20–23)
25.7 (21.6–29.8)
84.7 (80.9–88.5)
42.6 (37.9–47.3)
2.0 (1.5–2.5)
24.4 (20.0–28.8)
97.0 (95.2–98.8)
85.7 (82.1–89.3)
75.6 (71.2–80.0)

CI = conﬁdence interval.
Data presented as percentage (95% CI) unless otherwise noted.

NOTE.
a

ﬁgure 1.

Use and perception of strength of evidence of key practices to prevent C. difﬁcile infection.

regularly use several practices to prevent CDI: contact
precautions, private rooms or cohorting of infected patients,
enhanced room cleaning of infected patients, and use of soap
and water for hand hygiene for infected patients. However,
only 69% reported regular use of disposable thermometers,
and 52% reported employing an antimicrobial stewardship
program. Greater than 80% of respondents also perceived the
strength of evidence for several practices to prevent CDI to be
high: use of contact precautions in patients with CDI, private
rooms or cohorting of infected patients, appropriately
enhanced room cleaning of infected patients, use of soap and
water for hand hygiene for infected patients, and antimicrobial
stewardship. The only practice for which there was a sizeable
gap between practice use and perceived strength of evidence
was antimicrobial stewardship. Strength of evidence for

antimicrobial stewardship was rated as high by 91% of
respondents but by only 52% in regard to regular use.

d is c u s s i o n
Several key ﬁndings emerged from our national survey. First,
most US hospitals reported using a surveillance system to
monitor for CDI among their patients. Herzig et al7 reported
that among the 37 US states and territories that have enacted
laws requiring reporting of healthcare-associated infection
data, over half have mandated reporting of CDI rates. Second,
reported use of several recommended practices is very high,
along with the corresponding perceived strength of evidence
for many of these practices. Finally, the gap between our
respondents’ reported regular use of antimicrobial stewardship
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and their perceived strength of evidence to support antimicrobial stewardship was the highest of any practice.
We are aware of 1 other national study that characterized to
some extent what US hospitals are doing to prevent CDI.
Speciﬁcally, a survey by Jarvis et al8 in 2008 found that more
than 91% of US hospitals used contact precautions for patients
with CDI.
The practice for which we found the largest discrepancy
between reported regular use and perceived strength of evidence
was antimicrobial stewardship. The overuse of antimicrobials
can lead to patient harm. Thus, antimicrobial stewardship has
recently emerged as an important patient safety practice.9
Greater than 60% of hospitalized patients receive antibiotics.10
Unfortunately, as much as 50% of antibiotic use in the hospital
setting may be inappropriate.9 The 2014 SHEA Compendium
states “appropriate antimicrobial use as a CDI prevention measure is essential to any CDI prevention program.”2
Several important limitations of our survey must be considered. First, we relied upon self-reporting by the lead infection control coordinator at each site. Second, while our
sampling strategy was designed to obtain a nationally representative sample, it is possible that participating hospitals were
different from nonparticipating hospitals, thereby making the
results less generalizable. Finally, we did not distinguish
between practices routinely used in CDI outbreak settings
from those used in nonoutbreak settings. We are aware that
certain interventions (eg, hand washing with soap and water,
use of bleach) are only recommended in outbreak settings
rather than endemic settings.2
We have provided a snapshot of practices US hospitals
currently use to prevent CDI. While nearly all US hospitals
report using surveillance to detect CDI, the use of antimicrobial stewardship programs to prevent CDI is lacking in
48% of hospitals despite the perceived high strength of
evidence to support such programs. Better understanding this
discrepancy and, more importantly, resolving it will be
important for clinicians, policy makers, and patients.
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